Form 4 for IPSC Century Therapeutics, Inc.
Accepted 2023-03-23 00:00:00 ET · period of report 2023-03-21 · accession 0001062993-23-007574 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-23 | 2023-03-21+ | IPSC | Borges Luis | CSO | S - Sale+OE | $3.72 | -144.9K | 43.8K | -77% | -$539.6K |
| DM | 2023-03-23 | 2023-03-21+ | IPSC | Borges Luis | CSO | M - OptEx | $1.03 | +350.2K | 109.4K | New | +$360.8K |
| DM | 2023-03-23 | 2023-03-21+ | IPSC | Borges Luis | CSO | M - OptEx | $0.00 | -350.2K | 294.1K | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | S | D | 15,597 | $3.55 | 249,083 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-23 | M | A | 220,930 | $1.03 | 264,680 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-21 | M | A | 63,616 | $1.03 | 107,366 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-21 | S | D | 63,616 | $3.77 | 43,750 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.935, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. |
| 5 | Common | Common Stock | 2023-03-22 | M | A | 65,698 | $1.03 | 109,448 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-22 | S | D | 65,698 | $3.72 | 43,750 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.79, inclusive. |
| 7 | Derivative | Stock Option (right to buy) | 2023-03-23 | M | D | 220,930 | $0.00 | 7,452 | D | $1.03 · — to 2029-07-17 | 220,930 Common Stock | (F3) The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. |
| 8 | Derivative | Stock Option (right to buy) | 2023-03-22 | M | D | 65,698 | $0.00 | 228,382 | D | $1.03 · — to 2029-07-17 | 65,698 Common Stock | (F3) The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. |
| 9 | Derivative | Stock Option (right to buy) | 2023-03-21 | M | D | 63,616 | $0.00 | 294,080 | D | $1.03 · — to 2029-07-17 | 63,616 Common Stock | (F3) The option vests 25% on April 1, 2020, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. |